drugset / Trial / NCT00663169
Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout
RandomizedParallel-groupDouble-blindTreatment
Summary
This is an exploratory proof-of-concept study to evaluate the safety and efficacy of canakinumab (ACZ885) for inflammation and pain associated with acute gouty arthritis.
Timeline
- Start
- 2008-04
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Canakinumab | Monoclonal antibody | 10 mg/kg | Intravenous |
| Comparator | Dexamethasone | Small molecule | 12 mg | Intravenous |